Related Experiment Video
Updated: Dec 23, 2025

Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
Unplanned Readmissions of Children With Epilepsy in the United States
Sudha Kilaru Kessler1, Leah J Blank2, Jennifer Glusman3
1Department of Neurology, Perelman School of Medicine, Philadelphia, Pennsylvania; Division of Pediatric Neurology, Department of Neurology, Perelman School of Medicine, Philadelphia, Pennsylvania; Pediatric Neurology Health Services Research Group, Department of Neurology, Perelman School of Medicine, Philadelphia, Pennsylvania.
Insights
Pediatric epilepsy readmissions occur in 10.4% of cases, with neurodevelopmental issues being key risk factors. Interventions should focus on these clinical comorbidities for better outcomes in children with epilepsy.
Area of Science:
- Pediatric Neurology
- Healthcare Quality Improvement
- Epidemiology
Background:
- Unplanned readmissions after pediatric epilepsy discharge in the U.S. remain understudied.
- Epilepsy is a frequent cause of childhood hospitalization.
Purpose of the Study:
- To determine the burden and characteristics of unplanned readmissions following pediatric epilepsy-related hospital discharge.
- To identify risk factors associated with these readmissions.
Main Methods:
- Retrospective cohort study using the 2013-2014 Nationwide Readmissions Database.
- Analysis of children aged 1-17 years discharged after nonelective epilepsy hospitalization.
- Descriptive statistics and logistic regression to assess readmission risk factors.
Main Results:
- 10.4% of pediatric epilepsy admissions resulted in readmission within 30 days.
- Epilepsy was the most common readmission diagnosis (24.9%).
- Neurodevelopmental diagnoses (cerebral palsy, intellectual disability, developmental delay), longer hospital stays, gastrostomy, and tracheostomy were associated with increased readmission risk. Medicare insurance was linked to a 34.4% readmission rate.
Conclusions:
- A benchmark pediatric epilepsy readmission rate of 10.4% can inform quality improvement initiatives.
- Clinical factors, particularly neurodevelopmental comorbidities, are stronger predictors of readmission than demographic characteristics.
- Targeting interventions towards children with neurodevelopmental comorbidities may effectively reduce pediatric epilepsy readmissions.
Background:
The burden and characteristics of unplanned readmission after epilepsy-related discharge in children in the United States is not known.
Methods:
We undertook a retrospective cohort study of children aged one to 17 years discharged after a nonelective hospitalization for epilepsy, sampled from the Healthcare Cost and Utilization Project's 2013 and 2014 Nationwide Readmissions Database. Descriptive statistics and logistic regression models were used to examine the characteristics of initial hospitalization and risk factors for readmission.
Results:
A total of 42,873 admissions for unique patients were identified, with 4470 (10.4%) leading to readmission within 30 days. The most common readmission diagnosis was epilepsy (24.9%). Neurodevelopmental diagnoses including cerebral palsy, intellectual disability, and developmental delay were associated with increased odds of readmission. Longer hospitalization, gastrostomy, and tracheostomy were also associated with readmission, but continuous electroencephalography use was not. Children insured by Medicare had a readmission rate of 34.4%, whereas there were no associations of readmission with other sociodemographic characteristics such as neighborhood, income, and sex.
Conclusions:
Seizures are among the most frequent reasons for hospitalization in children. Establishing a benchmark readmission rate for pediatric epilepsy of 10.4% may be useful to health systems designing quality improvement efforts. Clinical factors were more strongly associated with readmission than demographic characteristics. Interventions to reduce pediatric epilepsy readmissions may have the highest yield when targeting children with neurodevelopmental comorbidities.
More Related Videos
10:22Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
Published on: December 6, 2016
09:16Use of a Wireless Video-EEG System to Monitor Epileptiform Discharges Following Lateral Fluid-Percussion Induced Traumatic Brain Injury
Published on: June 21, 2019
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Pharmacokinetics in Pediatric Patients: Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Metabolism